{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T03:35:02Z","timestamp":1784950502071,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005716","name":"Babol University of Medical Sciences","doi-asserted-by":"publisher","award":["724135346"],"award-info":[{"award-number":["724135346"]}],"id":[{"id":"10.13039\/501100005716","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.neulet.2026.138617","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:07:33Z","timestamp":1777522053000},"page":"138617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Metformin attenuates neurodegeneration in ICV-STZ-induced Alzheimer\u2019s model via antioxidant and anti-inflammatory mechanisms: implications for disease-modifying therapy"],"prefix":"10.1016","volume":"880","author":[{"given":"Mohamadkazem","family":"Darzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7902-0252","authenticated-orcid":false,"given":"Ravieh","family":"Golchoobian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein Najafzadeh","family":"Varzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzane","family":"Shanehbandpour Tabari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2026.138617_b0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.neulet.2026.138617_b0010","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3390\/antiox13101208","article-title":"The dual role of amyloid Beta-Peptide in oxidative stress and inflammation: unveiling their connections in Alzheimer\u2019s disease etiopathology","volume":"13","author":"Fanlo-Ucar","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.neulet.2026.138617_b0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054722","article-title":"Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation","volume":"8","author":"Di Penta","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2026.138617_b0020","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s12035-015-9132-3","article-title":"Intracerebroventricular streptozotocin injections as a model of Alzheimer\u2019s disease: in search of a relevant mechanism","volume":"53","author":"Grieb","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neulet.2026.138617_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118420","article-title":"Pharmacokinetic study and neuropharmacological effects of atractylenolide \u2162 to improve cognitive impairment via PI3K\/AKT\/GSK3\u03b2 pathway in intracerebroventricular-streptozotocin rats","volume":"333","author":"Liu","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.neulet.2026.138617_b0030","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1007\/s11095-017-2199-y","article-title":"Metformin\u2013a future therapy for neurodegenerative diseases: Theme: Drug Discovery, Development and delivery in Alzheimer's Disease guest editor: Davide Brambilla","volume":"34","author":"Markowicz-Piasecka","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.neulet.2026.138617_b0035","doi-asserted-by":"crossref","unstructured":"Y.-W. Wang, S.-J. He, X. Feng, J. Cheng, Y.-T. Luo, L. Tian, Q. Huang, Metformin: a review of its potential indications, Drug design, development and therapy (2017) 2421-2429. https:\/\/doi.org\/10.2147\/DDDT.S141675.","DOI":"10.2147\/DDDT.S141675"},{"key":"10.1016\/j.neulet.2026.138617_b0040","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2315106","article-title":"Metformin Ameliorates A\u03b2 Pathology by Insulin\u2010Degrading Enzyme in a Transgenic Mouse Model of Alzheimer\u2019s Disease","volume":"2020","author":"Lu","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neulet.2026.138617_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120538","article-title":"Intranasal metformin treatment ameliorates cognitive functions via insulin signaling pathway in ICV-STZ-induced mice model of Alzheimer's disease","volume":"299","author":"Kazkayasi","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.neulet.2026.138617_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e17873","article-title":"Metformin restores cognitive dysfunction and histopathological deficits in an animal model of sporadic Alzheimer's disease","volume":"9","author":"Rabieipoor","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.neulet.2026.138617_b0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3233\/JAD-2011-110284","article-title":"Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease","volume":"26","author":"Torres","year":"2011","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/j.neulet.2026.138617_b0060","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.3390\/cells14141064","article-title":"Neuroprotective Effects of Metformin through the Modulation of Neuroinflammation and Oxidative stress","volume":"14","author":"Reed","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.neulet.2026.138617_b0065","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s10787-023-01163-7","article-title":"Long-term use of metformin and Alzheimer\u2019s disease: beneficial or detrimental effects","volume":"31","author":"Al-Kuraishy","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.neulet.2026.138617_b0070","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.3390\/ijms23115938","article-title":"An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases","volume":"23","author":"Teleanu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neulet.2026.138617_b0075","article-title":"Role of oxidative stress in neurodegenerative disorders: a review of reactive oxygen species and prevention by antioxidants","author":"Houldsworth","year":"2024","journal-title":"Brain Communications 6"},{"key":"10.1016\/j.neulet.2026.138617_b0080","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s11011-014-9632-2","article-title":"Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia","volume":"30","author":"Ashabi","year":"2015","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neulet.2026.138617_b0085","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.nbd.2013.07.005","article-title":"Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis","volume":"59","author":"Schrag","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2026.138617_b0090","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jdiacomp.2013.05.006","article-title":"Comparative effects of pioglitazone and metformin on oxidative stress markers in newly diagnosed type 2 diabetes patients: a randomized clinical trial","volume":"27","author":"Mirmiranpour","year":"2013","journal-title":"J. Diabetes Complications"},{"key":"10.1016\/j.neulet.2026.138617_b0095","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1463-1326.2000.00089.x","article-title":"Effect of four\u2010week metformin treatment on plasma and erythrocyte antioxidative defense enzymes in newly diagnosed obese patients with type 2 diabetes","volume":"2","author":"Pavlovi\u0107","year":"2000","journal-title":"Diabetes. Obes. Metab."},{"key":"10.1016\/j.neulet.2026.138617_b0100","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.clnu.2012.08.006","article-title":"Effects of metformin on markers of oxidative stress and antioxidant reserve in patients with newly diagnosed type 2 diabetes: a randomized clinical trial","volume":"32","author":"Esteghamati","year":"2013","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.neulet.2026.138617_b0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11011-024-01422-8","article-title":"Metformin effectively alleviates the symptoms of Alzheimer in rats by lowering amyloid \u03b2 deposition and enhancing the insulin signal","volume":"40","author":"Abosharaf","year":"2024","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.neulet.2026.138617_b0110","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s13238-021-00858-3","article-title":"Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model","volume":"12","author":"Xu","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.neulet.2026.138617_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2024.100013","article-title":"Microglial activation states and their implications for Alzheimer's Disease","author":"Valiukas","year":"2025","journal-title":"J. Prev Alzheimers Dis."},{"key":"10.1016\/j.neulet.2026.138617_b0120","doi-asserted-by":"crossref","unstructured":"Q. Jin, J. Cheng, Y. Liu, J. Wu, X. Wang, S. Wei, X. Zhou, Z. Qin, J. Jia, X. Zhen, Improvement of functional recovery by chronic metformin treatment is associated with enhanced alternative activation of microglia\/macrophages and increased angiogenesis and neurogenesis following experimental stroke, Brain, behavior, and immunity 40 (2014) 131-142. https:\/\/doi.org\/ 10.1016\/j.bbi.2014.03.003.","DOI":"10.1016\/j.bbi.2014.03.003"},{"key":"10.1016\/j.neulet.2026.138617_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpet.2024.100042","article-title":"Metformin finding its way into the central nervous system: Combating neurological diseases?","volume":"392","author":"Cignarella","year":"2025","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394026001163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394026001163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:11:13Z","timestamp":1783163473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394026001163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":25,"alternative-id":["S0304394026001163"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2026.138617","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin attenuates neurodegeneration in ICV-STZ-induced Alzheimer\u2019s model via antioxidant and anti-inflammatory mechanisms: implications for disease-modifying therapy","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2026.138617","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"138617"}}